UH Spinouts
UH is strong in biotech and materials-related research, resulting in the launch many promising spinouts over the last decade to commercialize technologies in these fields and others. UH Spinouts have raised over $60M since 2016 in both dilutive and non-dilutive funding.
Latest News
- BioTools Innovator Selects UH Spinout as a Top Life Sciences Company
- Nice Issues a Positive Medtech Innovation Briefing for Endomag's Magtrace® Breast Cancer Lymphatic Tracer
- Smartphone-based Rapid COVID-19 Test Hits the Market
- UH Spinout, Curran Biotech, Show New Capture Coating
- UH Startup Auravax Therapeutics Forms Advisory Board Led by Genome Engineer George Church
- Alercell to Distribute UH Spin-out Luminostic's Clip COVID Rapid Antigen Test
- Curran Biotech’s New Nanocoating Could Prevent Indoor Transmission of COVID-19
- UH Spinout CellChorus Wins Big at Venture Houston 2021
- Commercializing Superconducting Wire Needed for Next-Generation Particle Accelerators
- Using magnetism to target breast tumors
Featured Startups
Of the nearly 50 companies that have come out of the university, many are actively commercializing UH technologies.
- HillMed Inc.
- Sanarentero
- Ampeers
- Exostretch
- Polymax Energy
- Animatus
- Lolaark
- CellChorus
- Amplify Chemicals and Polymers
- Booxby
- Resthetics
- GRoK Technologies
- Keros Therapeutics
- Delta Geo
- Wavve
- NextmiRNA Technologies
- REEcycle
- OnVi Biopharm
- Luminostics
- Denali Therapeutics
- Intelligent Surgical Devices
- Smart Grid Intelligent Management
- BSX Athletics
- Seprox
- Alzeca Biosciences
- Lytica Oncology
- C-4 Imaging
- Metal Oxide Technologies
- Endomagnetics
- Integricote
- Eureka Genomics
- Metabocentric Biotechnologies
- Elemental Coatings
- Teomics
- Sensytec